Form 4 for ATRA Atara Biotherapeutics, Inc.
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0000905148-25-000863 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-05 | 2025-03-03 | ATRA | Henrich Jill | EVP, Chief Regulatory Off | S - Sale | $7.00 | -1,059 | 18.7K | -5% | -$7,413 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-03 | S | D | 1,059 | $7.00 | 18,679 | D | — | — | (F2) The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 3, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees. (F3) This amount includes 360 shares purchased under the Issuer's Employee Stock Purchase Plan on November 29, 2024. |